Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AtriCure (ATRC) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for AtriCure (ATRC) over the last 17 years, with Q3 2025 value amounting to $24.1 million.

  • AtriCure's Free Cash Flow rose 4705.42% to $24.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $33.0 million, marking a year-over-year increase of 295979.2%. This contributed to the annual value of $745000.0 for FY2024, which is 10991.48% up from last year.
  • AtriCure's Free Cash Flow amounted to $24.1 million in Q3 2025, which was up 4705.42% from $19.0 million recorded in Q2 2025.
  • AtriCure's 5-year Free Cash Flow high stood at $24.1 million for Q3 2025, and its period low was -$28.0 million during Q1 2022.
  • In the last 5 years, AtriCure's Free Cash Flow had a median value of -$2.1 million in 2023 and averaged -$2.1 million.
  • Its Free Cash Flow has fluctuated over the past 5 years, first plummeted by 29913.59% in 2022, then skyrocketed by 734057.97% in 2024.
  • Over the past 5 years, AtriCure's Free Cash Flow (Quarter) stood at -$2.4 million in 2021, then tumbled by 71.23% to -$4.1 million in 2022, then surged by 130.16% to $1.2 million in 2023, then surged by 152.65% to $3.1 million in 2024, then surged by 667.13% to $24.1 million in 2025.
  • Its Free Cash Flow was $24.1 million in Q3 2025, compared to $19.0 million in Q2 2025 and -$13.2 million in Q1 2025.